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In its initial formulation, the concept of basic symptoms (BSs) integrated findings on the 
early symptomatic course of schizophrenia and first in vivo evidence of accompanying 
brain aberrations. It argued that the subtle subclinical disturbances in mental processes 
described as BSs were the most direct self-experienced expression of the underlying 
neurobiological aberrations of the disease. Other characteristic symptoms of psychosis 
(e.g., delusions and hallucinations) were conceptualized as secondary phenomena, 
resulting from dysfunctional beliefs and suboptimal coping styles with emerging BSs 
and/or concomitant stressors. While BSs can occur in many mental disorders, in partic-
ular affective disorders, a subset of perceptive and cognitive BSs appear to be specific 
to psychosis and are currently employed in two alternative risk criteria. However, despite 
their clinical recognition in the early detection of psychosis, neurobiological research on 
the aetiopathology of psychosis with neuroimaging methods has only just begun to con-
sider the neural correlate of BSs. This perspective paper reviews the emerging evidence 
of an association between BSs and aberrant brain activation, connectivity patterns, 
and metabolism, and outlines promising routes for the use of BSs in aetiopathological 
research on psychosis.
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iNtrODUctiON
Over the past two decades, preventive research in psychosis has renewed interest in subjective and 
subclinical psychopathology beyond positive and negative symptoms. One approach to a detailed 
description of such subtle disturbances, developed since the 1960s, is Huber’s “basic symptoms” 
(BSs) concept (Figure S1 in Supplementary Material).
tABLe 1 | cHr criteria according to the Bss concept.
cognitive disturbances (cOGDis)
≥2 of the following 9 BSs with at least weekly occurrence (i.e., SPI-A/SPI-CY 
score of ≥3) within the last 3 months
•  Inability to divide attention (B1a) between a (semi-)automatic and another 
task that strain different senses, e.g., making a sandwich (visual) while 
conversing (auditory)
•  Thought interference (C2) of completely irrelevant, random thought 
contents
•  Thought blockages (C3) incl. trailing off mentally and leading to a 
(temporary) loss of intended thought
•  Disturbance of receptive speech (C4), i.e., a disturbance in the immediate 
understanding of verbal stimuli in one’s mother tongue
•  Disturbance of expressive speech (C5), i.e., in the presence of a clear 
idea, a disturbance in the immediate access to the adequate word in one’s 
mother tongue
•  Thought pressure (D3), i.e., rapid succession of irrelevant, unrelated 
thoughts
•  Unstable ideas of reference (D4), experienced with immediate insight
•  Disturbances of abstract thinking (O3), i.e., initial literal understanding of 
metaphoric contents or symbols
•  Captivation of attention by details of the visual field (O7) that are random 
and irrelevant
cognitive-perceptive basic symptoms (cOPer)
≥1 of the following 10 BSs with at least weekly occurrence (i.e., SPI-A/SPI-CY 
score of ≥3) within the last 3 months and 1st occurrence ≥12 months ago 
(irrespective of frequency and persistence during this time)
•  Thought interference (C2)
•  Thought blockages (C3)
•  Disturbance of receptive speech (C4)
•  Thought pressure (D3)
•  Unstable ideas of reference (D4)
•  Thought perseveration (O1), i.e., repeated intrusion of irrelevant thought 
contents
•  Decreased ability to discriminate between ideas/perception, fantasy/true 
memories (O2), i.e., unfounded consideration of perceptions or memories 
as products of current imagination
•  Derealization (O8), incl. reduction to 2-dimensional vision and increased 
emotional involvement into the surrounding
•  Visual perception disturbances, excl. blurred vision and hypersensitivity to 
light (D5, F2, F3, and O4), i.e., perceptive distortions that are immediately 
recognized as own misperceptions
•  Acoustic perception disturbances, excl. hypersensitivity to sounds (F5 and 
O5), as above
aItem numbers refer to the “Schizophrenia Proneness Instrument, Adult Version (SPI-A)” 
that gives more extended descriptions of BS and instructions for their assessment (12).
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the concept of Basic symptoms
Basic symptoms are subtle, subclinical disturbances in stress tol-
erance, drive, affect, thinking, speech, (body) perception, motor 
action, and central-vegetative functions that are self-experienced 
with full insight into their abnormal nature (1, 2). Despite hav-
ing insight, people find these subjective experiences so new 
and strange that they remain almost inexplicable, and therefore 
usually require guided questioning for their assessment. Being 
different from what is considered to be one’s “normal” mental 
state, BSs remain predominately private and apparent only to 
the individual. Thus, rather than BSs themselves, it will be a 
person’s affective reactions and self-initiated coping strategies in 
response to their BSs that may be recognized by others. Therefore, 
BSs differ from (secondary) negative symptoms in their current 
understanding as dysfunctional mental and behavioral response 
observable to others (3). Being experienced with full insight, BSs 
are also distinct from positive symptoms which are experienced 
by the individual as real, normal thinking, and feeling (2, 4).
Basic symptoms are an integral part of psychosis and 
appear throughout various stages of the disorder (Figure S1 in 
Supplementary Material). In combination with selected attenu-
ated psychotic symptoms (APS), a subgroup of BSs was recently 
conceptualized as “self-disorders” (SDs) and a core schizophrenia 
vulnerability phenotype [Figures  S2 and S3 in Supplementary 
Material (5–7)].
Basic symptoms and early 
Neurobiological research
Huber’s pioneer pneumoencephalographic in  vivo studies on 
chronic schizophrenia patients with persistent negative or deficit 
symptoms led him to initially assume that a deficit syndrome 
characterized by BSs was caused in most cases by an atrophy of 
the basal ganglia and inherent small dysplastic lateral ventricles 
(8). Later on, he put emphasis on the limbic system by conceptu-
alizing BSs as “substrate-close” or “basic,” i.e., the most immediate 
symptomatic “expression of pathologically cerebral function in 
the region of the integrative system, which is responsible for the 
regulation of the cerebral filter and protection processes” [(9) p. 
78]. While structural changes would be irreversible and poten-
tially progressive, Huber (9) hypothesized that abnormal rhythms 
in EEG related to functional structures of the limbic system would 
only be seen in certain active (particularly early) stages.
Basic symptoms and risk for Psychosis
While studies in the 1980s and 1990s indicated that most BSs are 
indeed not specific to psychosis and may occur in other, especially 
non-psychotic affective disorders (4), 14 BSs were specific to the 
development of first-episode schizophrenia within 9.6 years (10) 
and employed in two clinical high risk (CHR) criteria (4, 11, 12): 
Cognitive Disturbances, COGDIS, Cognitive-Perceptive BSs, 
and COPER (Table 1).
A recent meta-analysis (11) revealed pooled conversion rates 
in COGDIS-defined samples of up to 54.9% within 4 years. Four-
year conversion rates of COGDIS samples were significantly 
higher than those of samples established by ultra-high risk (UHR) 
criteria (11), mainly by APS. Thus, COGDIS is one of three criteria 
recommended for CHR assessment by the European Psychiatric 
Association (11).
Neurocognition and Basic symptoms
Neurocognitive deficits are a common feature of schizophrenia 
and are also reported in CHR samples (13). To date, few studies 
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separately examined BSs samples and reported rather inconsist-
ent findings. Generally, patients exclusively meeting BSs criteria 
performed intermediate to UHR patients and controls. While 
neurocognitive deficits and cognitive BSs did not correlate, there 
is some evidence for an association between exclusive presence 
of COPER and executive control/verbal memory dysfunction 
(Table 2) (14). Thus, BSs samples without APS or brief limited 
intermittent psychotic symptoms (BLIPS) exhibit fewer and less 
pronounced neurocognitive impairments compared to samples 
with APS/BLIPS. This might indicate that BSs generally precede 
neurocognitive impairments.
BAsic sYMPtOMs AND cUrreNt 
NeUrOBiOLOGicAL reseArcH iN 
PsYcHOsis
Neurochemistry and Basic symptoms
Neurochemical findings suggest a role for dopaminergic, gluta-
matergic, serotonergic, and GABAergic systems in schizophrenia 
(44, 45). In vivo research on CHR states, defined by either UHR or 
BSs criteria, has focused mainly on dopamine (46, 47), glutamate 
(48, 49), and GABA (50, 51). Currently, the strongest evidence 
comes from Positron Emission Tomography studies indicating 
an increase of presynaptic striatal dopamine synthesis in APS 
patients compared with controls (46, 47). In addition, an increased 
dopamine synthesis capacity was also reported for individuals at 
genetic high risk for schizophrenia (52). Dopamine studies in BSs 
samples however are still missing.
These neurochemical studies have been complemented by 
pharmacological models of psychosis, e.g., the ketamine and 
endocannabinoid models (22, 23). Ketamine is an NMDA 
receptor antagonist, whereas cannabis or delta-9 tetrahydro-
cannabinol (THC) is an agonist on the cannabinoid receptor 
CB1. While commonly the effect of substances has to be 
ruled out to rate subjective experiences as BSs, recent studies 
ignoring this rule demonstrated an association of cannabis 
and ketamine use with cognitive and perceptive BSs (22, 23). 
Cannabis-using CHR patients had more BSs than non-using 
patients (22), while non-CHR cannabis users had significantly 
more positive, disorganization, general symptoms and BSs 
and also more neurocognitive deficits than non-users (23). 
Furthermore, the profiles of BSs and neurocognitive deficits of 
high-potency cannabis and ketamine users resembled COPER 
patients who subsequently converted to psychosis more closely 
than the profiles of users of other substances (23). Additional 
support of an association between the endocannabinoid system 
and BSs comes from one study investigating anandamide a bio-
active lipid binding to cannabinoid receptors, in the cerebro-
spinal fluid (CSF) of CHR states (24). CHR individuals with 
higher anandamide levels showed a lower risk for transitioning 
to psychosis. Finally, one study of the metabolic profile in CSF 
(25) reported increased levels of glucose and VGF peptide (a 
polypeptide expressed by neurons and neuroendocrine tis-
sues), and decreased levels of lactate and transthyretin protein 
in CHR patients (Table 2).
electrophysiology and Basic symptoms
EEG and magnetoencephalographic (MEG) recordings permit 
the non-invasive assessment of electric currents of large popula-
tions of neurons, thus providing an estimate of both spontaneous 
and task-induced activity with millisecond resolution.
In a study of event-related potentials (ERP: P100, N170, and 
N250) using a facial recognition paradigm (26), emotion recogni-
tion was reduced in CHR groups and accompanied by a decrease 
in ERP amplitudes. As emotion recognition is already completed 
within 100 msec (53), these findings may reflect more complex 
perceptual processes. Further research on their relation to visual 
BSs may be promising. Moreover, reduced P300 amplitudes dur-
ing an auditory oddball paradigm were found in a CHR sample 
(27). The COPER group showed a significant lower amplitude at 
a left temporoparietal site, whereas the APS/BLIPS group elicited 
smaller amplitudes at midline and left hemispheric electrode sites. 
These findings suggest potential differences in ERPs between BSs-
defined and APS-defined CHR patients that might be related to 
different states of disturbed information processing.
In addition, Arnfred et al. (28) examined correlations between 
proprioceptively evoked event-related responses and changes in 
SDs in a small sample of schizophrenia patients. EEG data were 
examined for the spectral power of evoked-activity at beta/
gamma-band frequencies (13–80  Hz) in response to a sudden 
change in muscle contraction. Increased total scores as well 
as increased ratings in the subscales “cognition and stream of 
consciousness,” “self-awareness and presence” and “bodily expe-
riences” correlated significantly with lower gamma-band activity 
over parietal electrodes and higher peak frequencies in beta-
activity (Table 2). Beside task-related activity, resting-state neural 
oscillations have also been recently investigated in CHR samples 
defined by both APS and BSs (31, 32), indicating increased delta/
theta-band activity with reduced alpha-band power (31) and 
reduced theta-band activity which correlated with neurocogni-
tive impairments (32), respectively. Moreover, there is emerging 
evidence that spontaneous gamma-band activity may differenti-
ate CHR patients from controls (33).
These findings provide preliminary evidence for a potential 
link between BSs and abnormalities in EEG parameters in 
patients with schizophrenia and CHR groups. However, it is 
essential for these findings to be replicated and expanded in 
large samples. Overall, data on aberrant neural oscillations 
and ERP-parameters are consistent with data from APS-only 
(54) and schizophrenia samples (55), suggesting a continuum 
between psychosis-risk and progression to ScZ. Thus, neural 
oscillations and their synchronization could constitute a can-
didate mechanism for BSs. During normal brain functioning, 
rhythmic activity, especially at gamma-frequency ranges, are 
important for ensuring effective communication between and 
within neuronal assembles and correlate with a range of cogni-
tive processes, including attention, perception, and working 
memory (55). Moreover, 30–80 Hz activity is generated by the 
interplay between GABAergic-interneurons and excitatory 
drive mediated through NMDA/AMPA-receptors (56, 57). 
These cellular mechanisms have been shown to be disrupted in 
schizophrenia (58).
tABLe 2 | summary of neurobiological studies of basic symptoms.
study Aims and hypotheses sample and assessments Main results Discussion and conclusion
NeUrOcOGNitive stUDies
Pukrop et al. 
(15)
Aim: identifying potential biobehavioral risk factors 
and investigate illness progression within a cross-
sectional design
Hypothesis: continuous decline of neurocognitive 
functioning in scope and intensity from COPER/
GRFD and APS/BLIPS to FEP and MEP
Sample: COPER/GRFD 
(n = 38), APS/BLIPS (n = 90), 
FEP (n = 86), MEP (n = 88)
Assessments: BSABS, SIPS/
SOPS; neurocognitive tests 
(VBM, CPT-IP, DRT, AVLT, ROFT, 
WCST, and verbal fluency
COPER/GRFD > APS/BLIPS > FEP > MEP
COPER/GRFD had abnormalities in verbal memory (immediate 
recall) and verbal executive function (verbal fluency)
Results support a neurodevelopmental 
model of psychosis with further progressive 
mechanisms and are consistent with a 
primary involvement of left frontotemporal 
networks in the prodromal phase
Simon et al. 
(16)
Aim: better understanding of cognitive functioning 
and its course in CHR states of psychosis
Hypotheses: (1) patients with BSs show cognitive 
impairment when compared with normative values 
and PCo and (2) these deficits are comparable to 
those observed in patients meeting UHR criteria
Sample: BS (n = 24), UHR 
(n = 69), FEP (n = 43), PCo 
(n = 49)
Assessments: SPI-A, SIPS/
SOPS; neurocognitive tests 
(MWT, LNS, TMT, verbal fluency, 
WCST, AVLT, and TAP)
BSs patients worse compared with normative data (working 
memory, verbal fluency), but not compared to PCo
BS > UHR
Most pronounced deficits affect executive 
functions and working memory → frontal 
lobe dysfunction in CHR groups
Schultze-
Lutter et al. 
(17)
Aim: possible association between subjective and 
objective cognitive disturbances and their relation to 
different CHR states
Hypotheses: COPER/GRFD less impaired than APS/
BLIPS; Association between subjective and objective 
cognitive disturbances
Sample: COPER/GRFD 
(n = 33), APS/BLIPS (n = 69)
Assessments: BSABS/SPI-A, 
SIPS/SOPS; neurocognitive 
tests (VBM, CPT-IP, DRT, LNS, 
SOPT, AVLT, ROFT, TMT, DST, 
WCST, and verbal fluency)
COPER/GRFD > APS/BLIPS
Association between subjectively reduced stress tolerance and 
processing speed
No further correlation between subjective cognitive–perceptive 
disturbances and performance in neurocognitive tests
Results support earlier findings showing 
lack of association between neurocognitive 
deficits and psychopathologic features. 
Possible additional predictive power of 
neurocognitive deficits in CHR states
Frommann 
et al. (14)
Aim: addressing the neurocognitive functions of 2 
different CHR groups in comparison to a healthy 
control group
Hypotheses: (1) CHR have generalized 
neurocognitive deficits compared with HC, (2) 
Measures of executive function and verbal memory 
are more impaired than those of other domains in the 
APS/BLIPS, and (3) Individuals in an COPER/GRFD 
are intermediate between HC and APS/BLIPS
Sample: COPER/GRFD 
(n = 116), APS/BLIPS (n = 89), 
HC (n = 87)
Assessments: ERIraos; 
neurocognitive tests (MWT, 
CPT-IP, LNS, SOPT, AVLT, TMT, 
DST, and verbal fluency)
HC > COPER/GRFD > APS/BLIPS
In COPER/GRFD executive control was significantly more 
impaired in comparison to the remaining domains.
In the APS/BLIPS the verbal memory domain was more 
impaired in comparison to the remaining domains
Executive control seems to be 
compromised in the COPER/GRFD 
(prior to the onset of positive symptoms), 
whereas verbal memory dysfunctions 
appear to evolve during a later prodromal 
stage
Simon et al. 
(18) [follow-
up of Simon 
et al. (16)]
Aim: long-term follow-up of CHR individuals and their 
cognitive performance. Comparing individuals who 
later convert to psychosis with those who do not 
convert to psychosis
Hypotheses: BSs individuals are less cognitively 
impaired than UHR individuals. UHR individuals 
that remit from an initial UHR status show cognitive 
impairment that is at intermediate position between 
BSs and non-remitting or converting UHR individuals
Sample: BS (n = 26), UHRrem 
(n = 35), UHRn-rem = 19, FEP 
(n = 48), PCo (n = 49)
Assessments: SPIA, SIPS/
SOPS; neurocognitive tests 
(MWT, LNS, TMT, verbal fluency, 
WCST, AVLT, and TAP)
At baseline, global cognitive functioning showed an increase 
of impairment from PCo to FEP (mean sum score of cognitive 
functioning: PCo > BS > UHRrem > UHRn-rem > FEP)
At baseline BS group was impaired, but less than UHR group 
(verbal memory, verbal fluency, executive functions)
Even in the absence of psychotic 
symptoms cognitive functioning, including 
executive functioning, was impaired in 
this CHR sample, this calls for strong 
efforts to address and remediate cognitive 
impairments as early as possible in CHR 
patients
(Continued)
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study Aims and hypotheses sample and assessments Main results Discussion and conclusion
Koutsouleris 
et al. (19)
Aim: can multivariate neurocognitive pattern 
classification facilitate the diagnostic identification of 
different CHR states for psychosis and facilitate an 
individualized prediction of illness transition
Hypotheses: (1) the employment of a support 
vector machine in conjunction with ensemble 
learning methods facilitates recognition of different 
CHR states and the prediction of frank psychosis. 
(2) Potentially complex patterns of cognitive 
ability derived from the combination of several 
neuropsychological tests may also facilitate the 
individualized prediction
Sample: HC (n = 30), COPER/
GRFD (n = 20), APS/BLIPS 
(n = 28)
Assessments: BSABS, 
CAARMS; neurocognitive tests 
(MWT, LNS, SOPT, DS, AVLT, 
TMT, DST, and verbal fluency)
COPER/GRFD patients performed worse in spatial working 
memory (SOPT) and, processing speed (TMT-A) and executive 
functions (TMT-B) compared to HC
The discriminative pattern of HC vs. COPER/GRFD showed 
high selection probabilities (>90%) in the working memory and 
verbal learning/memory domain
The binary classification results suggest 
that a pattern of altered verbal and 
mnemonic functions may reliably 
distinguish CHR individuals experiencing 
predictive basic symptoms from healthy 
controls
Haug et al. 
(20)
Aim: explore the relationships between SDs, as 
measured by the EASE, and neurocognitive test 
performance in the early phase of schizophrenia
Hypothesis: there are some associations between 
SDs and neurocognitive deficits, and that higher 
SDs would correlate with poorer neurocognitive 
performance
Sample: SZ (n = 57)
Assessments: EASE; 
neurocognitive tests (DST, LNS, 
Logical Memory Test of WMS, 
ROFT, and DKEFS)
EASE total score was significantly associated with verbal 
memory (high levels of SDs were associated with impaired 
verbal memory)
No association with SDs and working memory, executive 
function or psychomotor speed
General lack of associations between SDs 
and neurocognition is that SDs and these 
specific neurocognitive functions could 
represent different basic expressions of 
the illness
Neurocognitive test situation is structured 
with little affective and somatosensory 
salience. In contrast, the questions asked 
in the EASE have focus on more subjective 
experiences in everyday situations where 
somatosensory and affective processes 
interact with neurocognition
Nordgaard 
et al. (21)
Aim: explore potential associations between SDs, 
neurocognitive performance, rationality and IQ in 
patients with schizophrenia
Hypothesis: there are some associations between 
SDs and neurocognitive performance
Sample: SZ (n = 31)
Assessments: EASE; 
neurocognitive tests (subtests 
from the Cambridge 
Neuropsychological Test 
Automated Battery)
No significant correlation was found between SDs and 
neurocognitive performance
SDs correlate significantly with rationality (tested with syllogism 
test)
The general lack of associations between 
SDs and neurocognitive performance 
suggests that these phenomena represent 
different aspects of the disorder – i.e., SDs 
seem to reflect aspects that are essential 
or specific to schizophrenia, whereas 
impaired neurocognitive performance 
does not
The association between rationality and 
SDs could signify, that high levels of SDs 
make the patient insensitive to detect 
violations of logic
NeUrOcHeMicAL AND DrUG stUDies
Korver et al. 
(22)
Aim: investigation of the relationship between 
cannabis use, UHR symptoms and neuropsychology
Hypothesis: Cannabis-using control subjects and 
UHR subjects show increased symptomatology and 
reduced neuropsychological functioning compared to 
non-using subjects
Sample: UHR subjects (n = 63, 
of them 34 cannabis users), HC 
(n = 58, of them = 28 cannabis 
users)
Assessments: SIPS, BSABS-P, 
CIDI (sections J and L); 
neurocognitive tests (FTT, CPT, 
CVLT, National Adult Reading 
Test, and verbal fluency)
More basic symptoms and UHR symptoms in cannabis-using 
UHR subjects compared to non-using UHR subjects
Cannabis-using control group showed more subclinical UHR, 
basic symptoms and more dysfunction than non-cannabis 
control subjects
Frequency of cannabis use correlated with severity of several 
UHR symptoms
No significant relationship between frequency of cannabis use 
and any neuropsychological test.
The association between frequency of 
cannabis use and UHR symptoms led 
to the assumption that frequent use of 
cannabis is related to changes in visual 
information processing
Frequent use of cannabis could represent 
a risk factor for developing subclinical UHR 
symptoms and impaired neurocognitive 
functioning in healthy subjects
tABLe 2 | continued
(Continued)
January 2016 | Volum
e 7 | A
rticle 9
5
S
chultze-Lutter et al.
R
evisiting the B
asic S
ym
ptom
 C
oncept
Frontiers in P
sychiatry | w
w
w
.frontiersin.org
study Aims and hypotheses sample and assessments Main results Discussion and conclusion
Morgan et al. 
(23)
Aim: (1) Assess the degree of basic symptoms in 
currently non-psychotic users of 3 classes of drugs, 
namely cannabis (high-potency cannabis), stimulants 
(cocain) and dissociative anesthetics (ketamine). (2) 
Investigate measures that have shown sensitivity to 
cognitive deficits in prodromal individuals
Hypothesis: are BSs and neurocognitive deficits 
present in individuals dependent on these drugs? 
Are BSs associated with drug use per se or do users 
of these different pharmacological agents display 
differing profiles?
Sample: N = 130; dependent 
high-potency cannabis users 
(n = 29), dependent cocaine 
users (n = 22), dependent 
ketamine users (n = 21), 
recreational drug users (n = 28), 
drug-naïve control (n = 30)
Assessments: SPI-A; 
neurocognitive tests (RBMT 
and STW)
Deficits in working memory were only found in ketamine users 
and deficits in frontal functioning in ketamine and high-potency 
cannabis users. Long-term memory was impaired in all drug 
users
The symptom profile associated with chronic ketamine use was 
similar to individuals with basic symptoms who subsequently 
make a transition to psychosis
Ketamine, high-potency cannabis and 
cocaine users showed basic symptoms, 
whereas ketamine users exhibited highest 
levels of basic symptoms
The existence of basic symptom-like 
phenomena is a potential mechanism 
by which heavy drug use triggers acute 
psychosis in vulnerable individuals
Koethe et al. 
(24)
Aim: to evaluate whether changes in the 
endocannabinoid system [i.e., Anandamide in 
cerebrospinal fluid (CSF)] are detectable in initial 
prodromal states of psychosis
Hypothesis: elevation of Anandamide in CSF is 
apparent in early stages of psychosis
Sample: HC (n = 81), UHR 
(n = 27)
Assessments: SPI-A, PANSS, 
SOPS
Cerebrospinal Anandamide levels in patients were significantly 
elevated. Patients with lower levels showed a higher risk for 
transiting to psychosis earlier
The up-regulation of Anandamide in 
the initial prodromal course suggests a 
protective role of the endocannabinoid 
system in early schizophrenia
Huang et al. 
(25)
Aim: to evaluate whether CSF alterations of glucose, 
lactate, VGF and transthyretin, that have been found 
in SZ, are already detectable in UHR
Hypothesis: none stated
Sample: FEP, drug naive 
(n = 54); UHR (n = 24); HC 
(n = 70)
Assessments: SPI-A, PANSS, 
SIPS/SOPS
~1/3 of UHR patients displayed proteomic/metabolic profiles 
characteristic of FEP, drug naive, i.e., changes in levels 
of glucose, lactate, VGF-derived peptide (VGF23-62) and 
transthyretin
Schizophrenia-related biochemical disease 
processes can be traced in CSF of 
prodromal patients
eLectrOPHYsiOLOGicAL stUDies
Wölwer et al. 
(26)
Aim: to investigate impairments of facial affect 
recognition and its neurophysiological correlates in 
two different CHR states
Hypothesis: CHR individuals show poorer affect 
recognition performance and abnormalities in ERP 
components as correlates of impaired encoding of 
facial features and affect decoding processes
Sample: HC (n = 32), COPER/
GRFD (n = 16), APS/BLIPS 
(n = 21)
Assessments: ERIraos Pictures 
of Facial Affect (6 basic 
emotions)
EEG: event-related potentials 
(ERP: P100, N170, N250)
Facial affect recognition in CHR < HC, no significant difference 
between CHR groups
Amplitudes of all three ERPs in CHR < HC (CHR groups were 
collapsed for ERP analysis)
(1) The ability to discriminate emotional 
expressions in faces is impaired in the 
CHR state (COPER/GRFD as well as APS/
BLIPS), demonstrating an impairment of 
social cognition already before the first 
psychotic episode
(2) Reduced N100 may be due to 
an impairment of fundamental visual 
processes, N170 may reflect dysfunctions 
in visual processing of facial structures. 
Diminished N250 amplitudes may indicate 
difficulties to associate the structural 
representation of the face with semantic 
and contextual information
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Frommann 
et al. (27)
Aim: to determine whether individuals in two different 
CHR states show P300 amplitude reductions and 
altered topography
Hypothesis: CHR individuals in both states show left 
temporoparietal amplitude reduction compared to 
controls
Sample: HC (n = 40), COPER/
GRFD (n = 50), APS/BLIPS 
(n = 50)
Assessments: ERIraos
EEG: ERP P300, oddball 
paradigm
Hit rate: APS/BLIPS = HC, COPER/GRFD = HC*
P300 latency: APS/BLIPS = HC, COPER/GRFD = HC*
*COPER/GRFD vs. APS/BLIPS not reported
P300 amplitude: sagittal midline (SM) and left hemisphere 
electrodes: APS/BLIPS < HC, COPER/GRFD = HC, APS/
BLIPS = COPER/GRFD
Sagittal midline: BLIPS positive < BLIPS negative
Left temporoparietal electrode: COPER/GRFD < HC
P300 activity in the COPER/GRFD differed 
only at left temporoparietal position from 
HC, whereas in the APS/BLIPS, markedly 
amplitude reductions were observed, 
pronounced over the left hemisphere
Findings may indicate a disturbance of 
neural generators in the left superior 
temporal lobe occurring early in the 
disease process. Temporoparietal P3 
reductions may indicate vulnerability to 
psychosis. Sagittal midline P3 amplitudes 
may reflect changes underlying the 
development of psychotic symptoms
Arnfred et al. 
(28)
Aim: explore potential associations between SDs and 
abnormalities of early contralateral proprioceptive 
evoked oscillatory brain activity
Hypothesis: none stated
Sample: SZ (n = 12)
Assessments: EASE
EEG: proprioceptive-evoked 
potentials
Higher EASE scores (i.e., increased SDs) were associated 
with lower peak parietal gamma frequencies and higher peak 
beta amplitudes over frontal and parietal electrodes in the left 
hemisphere following right-hand proprioceptive stimulation
SDs may be associated with dysfunction of 
early phases of somatosensory processing
Sestito et al. 
(29)
Aim: to investigate the relation between SDs and 
subtle, schizophrenia-specific impairments of 
emotional resonance that are supposed to reflect 
abnormalities in the mirror neurons mechanism. 
To test whether electromyographic response to 
emotional stimuli (i.e., a proxy for subtle changes 
in facial mimicry and related motor resonance 
mechanisms) would predict the occurrence of 
anomalous subjective experiences (i.e., SDs)
Hypothesis: none stated
Sample: SZ spectrum (n = 18)
Assessments: BSABS
EMG: multimodal 
paradigm, recording facial 
electromyographic activity of 
muscles in response to positive 
and negative emotional stimuli
SZ spectrum patients showed an imbalance in emotional motor 
resonance with a selective bias toward negative stimuli, as well 
as a multisensory integration impairment. Multiple regression 
analysis showed that electromyographic facial reactions in 
response to negative stimuli presented in auditory modality 
specifically and strongly correlated with SDs subscore
The study confirms the potential of SDs 
as target phenotype for neurobiological 
research and encourages research into 
disturbed motor/emotional resonance as 
possible body-level correlate of disturbed 
subjective experiences in SZ spectrum
Sestito et al. 
(30)
Aim: to explore whether a low or high emotional 
motor resonance occurring in SZ spectrum relates to 
clinical features and BSs
Hypothesis: none stated
Sample: SZ spectrum (n = 19)
Assessments: BSABS
EMG: multimodal 
paradigm, recording facial 
electromyographic activity of 
muscles in response to positive 
and negative emotional stimuli
SZ spectrum patients more resonating with negative emotional 
stimuli (i.e., externalizers) had significantly higher scores in 
BSABS Cluster 3 (vulnerability) and more psychotic episodes 
than internalizers patients. SzSp patients more resonating with 
positive emotional stimuli (i.e., externalizers) scored higher in 
BSABS Cluster 5 (interpersonal irritation) than internalizers
Abnormal subjective experiences are 
related to low-level emotional motor 
mechanisms disruption, indexed by 
electromyographic facial reactions
Van Tricht 
et al. (31)
Aim: quantitative EEG spectral power and alpha peak 
frequencies (APF) were determined in CHR subjects
Hypothesis: none stated
Sample: CHR (n = 113), HC 
(n = 25)
Assessments: SPI-A, SIPS/
SOPS
EEG: Ag/AgCl electrodes 
were applied according to the 
international 10–20 system; 
individual APF were assessed
Compared to CHR without transition HC, CHR with transition 
showed higher theta and delta on frontal and central scalp 
locations and lower occipital-parietal APF. Furthermore, in CHR 
without transition, upper parietal alpha was lower compared 
to HC. A model for prediction of psychosis included frontal 
theta and delta as well as the APF as predictors of 18-month 
conversion rates
Theta and delta ranges and APF can 
contribute to the short-term prediction of a 
first psychotic episode
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Andreou 
et al. (32)
Aim: investigate EEG resting-state connectivity in 
CHR compared to SZ spectrum and HC, and its 
association with cognitive deficits
Hypothesis: none stated
Sample: CHR (n = 28), SZ 
spectrum (n = 16), HC (n = 23)
Assessments: SPI-A, SIPS/
SOPS; Neurocognitive tests 
(VLMT, WMS, TMT, LNS, DS, 
DST, verbal fluency)
EEG: 64-channel resting state 
EEG recordings (eyes closed).
SZ displayed increased theta-band resting-state multivariate 
interaction measure connectivity across midline, sensorimotor, 
orbitofrontal regions and the left temporoparietal junction. CHR 
displayed intermediate theta-band connectivity patterns that did 
not differ from either SZ or HC: mean theta-band connectivity 
within the above network partially mediated verbal memory 
deficits in SZ and CHR
Aberrant theta-band connectivity 
may represent a trait characteristic 
of schizophrenia associated with 
neurocognitive deficits
Ramyead 
et al. (33)
Aims: to assess whether abnormalities in 
current source density (CSD) and lagged phase 
synchronization of oscillations across distributed 
regions of the brain already occur in patients with 
CHR state for psychosis
Hypotheses: (1) CHR with transition would 
demonstrate abnormal CSD in both the high gamma 
and beta frequency bands when compared with 
CHR without transition and HC. (2) The lagged phase 
synchronization of beta, the long-range modulator, 
would be more decreased in CHR with transition 
compared to CHR without transition and HC as a 
function of increasing Euclidian distance
Sample: CHR (n = 63), HC 
(n = 29)
Assessments: BSIP; 
neurocognitive tests (TAP)
EEG: resting-state EEG
CHR with transition showed higher gamma activity in the medial 
prefrontal cortex compared to HC, which was associated with 
abstract reasoning abilities in CHR with transition. Furthermore, 
in CHR with transition lagged phase synchronization of beta 
oscillations decreased more over Euclidian distance compared 
to CHR without transition and HC. Finally, this steep spatial 
decrease of phase synchronicity was most pronounced in 
CHR with transition patients with high positive and negative 
symptoms scores
Patients who will later make the transition 
to psychosis are characterized by 
impairments in localized and synchronized 
neural oscillations providing new insights 
into the pathophysiological mechanisms of 
schizophrenic psychoses and may be used 
to improve the prediction of psychosis
iMAGiNG stUDies: strUctUrAL
Hurlemann 
et al. (34)
Aims: to which extent interrelated structural–
functional deficits of the hippocampus reflect a 
vulnerability to schizophrenia?
Hypothesis: hippocampal volume reduction should 
be paralleled by a progressive worsening of verbal 
learning and memory
Sample: COPER/GRFD 
(n = 20), APS/BLIPS (n = 16), 
HC (n = 30)
Assessments: ERIraos; 
neurocognitive tests (MWT and 
AVLT)
Hippocampal volume decrease in COPER/GRFD of 7.7%
In APS/BLIPS but not in COPER/GRFD, a 9.2% deficit in AVLT 
(delayed recall) was correlated with reduced MRI hippocampal 
volumes
Progressive and interrelated structural–
functional pathology of the hippocampus 
could be an index of increased risk for 
schizophrenia
Koutsouleris 
et al. (35)
Aims: (1) to investigate structural brain differences 
between participants with COPER/GRFD or APS/
BLIPS. (2) To examine associations between 
structural differences and later disease conversion
Hypothesis: no hypothesis stated
Sample: COPER/GRFD 
(n = 20), APS/BLIPS (n = 26), 
HC (n = 75); 4-year follow-up 
(total n = 33; 13 for COPER/
GRFD and 20 for APS/BLIPS), 
15 transitioned to psychosis 
[COPER/GRFD (n = 1), APS/
BLIPS (n = 14)]
Gray matter reductions (controls > COPER/GRFD) in fusiform, 
superior, middle and inferior temporal gyri, as well as amygdala 
and hippocampus, bilaterally. For COPER/GRFD > APS/BLIPS, 
differences in frontal clusters in left subgenual anterior cingulate 
cortex as well as in the ventromedial prefrontal cortex and 
dorsomedial prefrontal cortex, bilaterally
BSs are associated with medial and lateral 
temporal lobe abnormalities, as well as 
subtle perisylvian, prefrontal, parietal, 
thalamic and cerebellar anomalies; APS/
BLIPS mark are characterized by more 
pronounced structural anomalies within 
these regions
Koutsouleris 
et al. (36)
Aims: to investigate the ability of support vector 
machines (SVMs) to detect different CHR states 
by performing a classification of HC vs. individuals 
with CHR (grouped into COPER/GRFD and APS/
BLIPS) and to further evaluate SVMs’ performance in 
predicting transition in the CHR converting to clinical 
disorders
Hypothesis: None stated
Sample: COPER/GRFD 
(n = 20), APS/BLIPS (n = 25), 
HC (n = 25); follow-up 13 for 
COPER/GRFD, and 20 for 
APS/BLIPS, 15 transitioned 
to psychosis [COPER GRFD 
(n = 1), APS/BLIPS (n = 14)]
Multivariate neuroanatomical pattern classification can 
accurately discriminate between COPER/GRFD, APS/BLIPS, 
and HC. COPER/GRFD patterns appear be distinguishable 
from HC on the basis of gray matter patterns of both 
augmentations and reductions in temporal lobe regions. They 
differ from APS/BLIPS on the basis of gray matter patterns 
around the cingulate cortex and the perisylvian fissure
COPER/GRFD without other CHR criteria, 
appear to be distinguishable from both 
HC and APS/BLIPS subgroups; however, 
the pattern linked to conversion is not 
as clear in COPER/GRFD as it is in APS/
BLIPS. This is partly due to the fact that 
a very low proportion of COPER/GRFD 
patients converted to psychosis (1 on 20) 
in this study
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Koutsouleris 
et al. (37)
Aims: to test the “accelerated aging” hypothesis 
across different psychiatric disorders, using brain 
age gap estimations; to employ multivariate pattern 
analysis (MPVA) to estimate classifiers’ ability to 
distinguish between different pathologies
Hypothesis: no hypothesis stated
Sample: COPER/GRFD 
(n = 21), APS/BLIPS (n = 68), 
major depression (n = 104), 
borderline personality disorder 
(n = 57), SZ (n = 141), HC 
(n = 437)
Results yield negative brainage effects in the COPER/GRFD 
group
It appears that the COPER/GRFD group 
showed “decelerated brain aging”; the 
authors suggest this effect could be due 
to a maturational delay mechanism, or a 
compensatory neural mechanism at the 
early stage of the disease
Tepest et al. 
(38)
Aims: to investigate interhemispheric connectivity, 
using measures of the corpus callosum (CC); to 
investigate corticocortical connectivity, using a 
gyrification index (GI) measure
Hypotheses: changes in both measures reflecting 
impairments in long distance as well as in short 
distance connectivity, in comparison with HC 
subjects
Sample: CHR (n = 21), SZ 
(n = 21), HC (n = 21)
GI frontal region
SZ > HC (+20%)
SZ > CHR (+9%)
CHR > HC (+10%)
GI parietal region
SZ > HC (+15%)
SZ > CHR (+8%)
CHR > HC (+7%)
Results suggest an impairment in short-
range corticocortical connectivity, whereas 
no impaired long-range connectivity no 
difference in CC measurements
iMAGiNG stUDies: FUNctiONAl
Ebisch et al. 
(39)
Aims: do FEP patients show functional activation 
abnormalities during social perception of other 
individuals’ affective tactile stimulation?
Hypothesis: none stated
Sample: FEP (n = 24), HC 
(n = 22)
Assessments: SPI-A, PANSS
fMRI: social perception task 
using videos depicting animate/
inanimate individuals using 
tactile stimulation
Ventral premotor cortex activation negatively correlates with 
SPI-A basic symptom scores (0–150)
Results likely reflect poor multisensory 
integration in the vPMC (visual, tactile, 
proprioceptive self-experiences)
Ebisch et al. 
(40)
Aims: investigate connectivity underlying the link 
between aberrant self-experience and social 
cognition in FEP
Hypothesis: none stated
Sample: FEP (n = 24), HC 
(n = 22)
Assessments: SPI-A, PANSS
fMRI: social perception task 
using videos depicting animate/
inanimate individuals using 
tactile stimulation
Connectivity between ventral premotor cortex and posterior 
cingulate cortex correlates with SPI-A basic symptom scores 
(0–150)
Increased functional coupling between 
antagonistic functional networks may alter 
functional segregation, thereby disturbing 
the relationship between the intrinsic (self-
referential) and extrinsic (interacting) self
Wotruba 
et al. (41)
Aims: to examine whether salience network (SN) 
disturbances can be evidenced in CHR. Furthermore, 
to explore if within and between intrinsic functional 
connectivity in the SN, default mode network (DMN) 
and task-positive network (TPN) are associated to 
symptoms related to reality distortions and cognitive 
processing in CHR subjects
Hypothesis: clinical symptoms and disturbances 
of cognition seen in CHR subjects are reflected by 
an aberrant spatial extent in DMN, TPN, and SN, 
accompanied by a loss of anticorrelation between 
those 3 networks
Sample: BS (n = 28), UHR 
(n = 19), HC (n = 29)
fMRI: resting-state paradigm
mPFC–rDLPFC connectivity, as well as rAI-PCC connectivity 
increased in BSs and UHR vs. HC (anticorrelated for controls). 
Significant anticorrelation between the task-positive network 
(bilateral fronto-parietal) and DMN for HC, but not CHR groups
Absence of typical anticorrelated patterns 
may relate to irregularities in discrimination 
between external and internal sources of 
information, thereby potentially leading 
to risk symptoms. Note however that 
no significant differences were found 
between BSs risk and UHR (UHR seems 
to show trend-like increased connectivity 
in rAI-PCC)
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Wotruba 
et al. (42)
Aims: explore functional brain correlates during both 
anticipation and receipt of rewards and to evaluate 
their association with symptoms in unmedicated 
persons at risk for psychosis
Hypotheses: (1) positive symptoms are associated 
with activation of the ventral striatum (VS) and the 
anterior insula during reward anticipation, (2) negative 
symptoms are associated with reduced VS activation 
during reward anticipation, and (3) depressive 
symptoms are associated with reduced VS and 
mOFC activation during processing of rewarding 
outcomes
Sample: CHR (n = 21) meeting 
UHR + BS criteria, HC (n = 24)
fMRI: monetary incentive delay 
task to probe neural responses 
for reward anticipation and 
receipt
During reward anticipation, increased in CHR: PCC, SFG, 
medial frontal gyrus. No correlations with BSs, but with SIPS 
positive in ventral striatum and rAI (positive correlation)
No group differences for receipt of reward contrast, correlations 
with psychopathology: left ventral striatum with negative 
symptoms (negative correlation)
Evidence for dysregulation of reward 
processing in risk period, with frontal 
compensation. Higher striatal activation 
might be linked to “increased salience” 
hypothesis in early stages
Ferri et al. 
(43)
Aim: to examine embodied simulation as driven by 
mirror neuron in schizophrenia
Hypothesis: none stated
Sample: SZ (n = 22), HC 
(n = 22)
fMRI: goal-related actions in 
either a neutral or emotional 
context
Lower activation of the left inferior parietal lobule when 
observing neutral action correlated with increased basic 
symptoms score
Emotional cues might allow SZ patients 
to recover mirror neuron-driven embodied 
simulation at least in part. However, 
their understanding of the emotional 
components of others’ actions will likely 
remain deficient
SPI-A, Schizophrenia Proneness Instrument, Adult version; SPI-CY, Schizophrenia Proneness Instrument, Child and Youth version; BSABS, Bonn Scale for the Assessment of Basic Symptoms; EASE, Examination of Anomalous 
Self-Experience; ERIraos, Early Recognition Inventory/Interview for the Retrospective Assessment of the Onset of Schizophrenia; SIPS/SOPS, Structured Interview for Prodromal Syndromes; CAARMS, Comprehensive Assessment of 
At Risk Mental States; CHR, clinical high risk; BSs, basic symptoms; SDs, self-disturbances; UHR, ultra-high risk; FEP, first-episode psychosis; MEP, multiple episode psychosis; SZ, schizophrenia; PCo, patient controls; HC, healthy 
controls.
Neurocognitive tests: MWT, Mehrfach–Wortschatz-Test; CPT-IP, Continuous Performance Test-Identical Pairs version; TAP, Testbatterie zur Aufmerksamkeitsprüfung; DRT, Delayed Response Task; LNS, Letter-Number Span; DS, 
Digit Span Test; SOPT, Subject Ordered Pointing Task; AVLT, Rey Auditory Verbal Learning Test; ROFT, Rey–Osterrieth Complex Figure Test; WMS, Wechsler Memory Scale; TMT, Trail-Making Tests; DST, Digit Symbol Test; WCST, 
Wisconsin Card Sorting Test; RBMT, Rivermead Behavioural Memory Test; STW, Spot The Word Test; FTT, Finger-Tapping Test; CVLT, California Verbal Learning Test.
Neuroimaging: vPMC, ventral premotor cortex; mPFC, medial prefrontal cortex; rDLPFC, right dorsolateral prefrontal cortex; PCC, posterior cingulate cortex; rAI, right anterior insula; SFG, superior frontal gyrus; mOFC, medial 
orbitofrontal cortex.
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Functional and structural imaging and 
Basic symptoms
To date, a handful of magnetic resonance imaging (MRI) studies 
have included the assessment of BSs by specialized instruments 
(Table 2). Their findings were similar to those reported for UHR 
and schizophrenia patients (59–61).
Structural Studies
Five studies have investigated structural characteristics in rela-
tion to BSs. These studies distinguished “early risk” for psychosis, 
characterized by either COPER or the UHR genetic risk criterion 
(GRFD) in the absence of symptomatic UHR states, from “late 
risk,” which encompasses individuals meeting APS or BLIPS 
criteria, irrespective of the presence of BSs (34–37). Hurlemann 
et al. (34) reported bilaterally reduced hippocampi in COPER/
GRFD and in APS/BLIPS subjects, correlating in the latter group 
with delayed recall in a verbal memory test. Koutsouleris et al. 
(35) employed voxel-based morphometry analyses to examine 
morphological differences between early- and late-risk samples. 
In comparison to controls, the COPER/GRFD group presented 
gray matter reductions involving the fusiform, superior, middle, 
and inferior temporal gyri, as well as amygdala and hippocam-
pus, bilaterally. While they were associated with medial and 
lateral temporal lobe abnormalities, as well as subtle perisylvian, 
prefrontal, parietal, thalamic, and cerebellar anomalies, these 
alterations were continuous with late-risk participants (35). 
In a parallel study using multivariate neuroanatomical pattern 
classification, morphological patterns of COPER/GRFD were 
distinguishable from controls on the basis of gray matter pat-
terns of both augmentations and reductions in temporal lobe 
regions; they differed from late risk on the basis of gray matter 
patterns covering the anteroposterior cingulate cortex and the 
perisylvian fissure (36). Using brain age gap estimations, the 
same group of participants reporting COPER/GRFD presented 
a “decelerated brain aging,” suggesting differential maturational 
dynamics at different stages of risk. Such deceleration could 
be due to a maturational delay mechanism, or a compensatory 
neural mechanism at the early stage of the disease (37). A further 
study indicated increased gyrification in frontal and parietal 
regions in BSs individuals (identified using COGDIS) compared 
to controls, implicating impaired short-range corticocortical 
connectivity (38).
Functional Imaging Studies
To date, only five fMRI studies have examined BSs (39–43). Studies 
examining cerebral activation in patients with schizophrenia 
consistently reported significant associations between BSs and 
localized decreased activations in the ventral premotor cortex 
(40) and in the left inferior parietal lobule during passive viewing 
of neutral actions (43). Notably, increased connectivity between 
ventral premotor cortex and posterior cingulate cortex was 
associated with the severity of BSs in first-episode schizophrenia 
patients (39). This is consistent with another study examining the 
relationship between task positive and default-mode connectivity 
in CHR subjects, which reported a lack of anticorrelation between 
task positive and task negative networks (41).
The preliminary nature of these studies does not enable any 
definite conclusion as to the links between altered functional 
connectivity and BSs. Differences in methodology as well as 
heterogeneity of samples, which included both CHR and frankly 
psychotic patients, limit the interpretation of the available results 
and likely contributed to their inconsistencies (62). Furthermore, 
the variety of BSs involved, which touch upon motivation, cogni-
tive and perceptual domains are likely to involve a variety cortical 
regions and networks. Overall, these pioneering studies suggest 
atypical patterns of neural activation in relation to BSs in terms of 
both reduced activity in discrete regions associated to self-other 
boundary distinction and atypical cross-talk between networks, 
which is similar to what is observed in UHR populations (59).
DiscUssiON AND PersPectives
current evidence
Although, in their original formulation, BSs were thought to 
reflect core abnormalities in brain functioning, investigations 
have only recently begun to look for their neurobiological origins, 
especially in CHR groups. Given the importance of BSs criteria 
in CHR research (11), further studies are needed to provide more 
detailed insights into the underlying neurobiological correlates 
that give rise to self-experienced disturbances in perception 
and cognition. Such candidate mechanisms could be of crucial 
importance for understanding the etiology of psychosis-risk as 
well as provide potential biomarkers for early detection and diag-
nosis. Moreover, such insights could point toward useful targets 
for novel pharmacological and psychological interventions that 
might ultimately reduce conversion rates.
Future studies into the Neurobiology of 
Basic symptoms
Current studies provide only preliminary evidence for neurobio-
logical mechanisms underlying BSs. Available data highlights that 
diverse anatomical, pharmacological and functional correlates 
may be involved in the manifestation of BSs in psychotic and 
CHR individuals. These include structural alterations, changes in 
ERPs and neural oscillations, neurotransmitter systems as well 
as evidence for changes in large-scale networks as assessed with 
fMRI. For more detailed and possibly mechanistic insights into 
neurobiology of BSs, different strategies need to be employed.
First, BSs in their original formulation are a heterogeneous set 
of symptoms comprising disturbances in perception, affect, drive, 
and cognition. Dimensional analyses of BSs indicated six BSs 
dimensions in adult psychosis patients that appear stable across 
various states of the illness [i.e., from the prodromal phase via 
the first episode to chronic states/relapse (4, 63)]. However, these 
six dimensions could not be replicated in a sample of early-onset 
schizophrenia patients, where four slightly different dimensions 
emerged [Figures S4–S6 and Table S1 in Supplementary Material 
(4)]. Thus, while past studies have either considered BSs in total 
(e.g., SPI-A sum score) or only considered COPER or COGDIS, 
BSs dimensions or even more differentiated BSs cluster (e.g., distin-
guishing even further between cognitive, speech, visual, and acous-
tic disturbances) might offer a more appropriate route to detecting 
neurobiological mechanisms underlying (if related to specific BSs) 
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or further promoting (if related to unspecific BSs) development of 
psychosis. Furthermore, as recently indicated for single attenuated 
and manifest psychotic “Ich-Störungen (64), even investigating the 
neurobiology of single BSs may provide some significant insight. 
For example, when considering subjective disturbances of recep-
tive and expressive speech as subtle, functional and only transient 
variants of receptive and amnesic aphasia, respectively (65), on a 
phenomenological level, it seems promising to investigate the role 
of brain regions which are highly correlated with theses neurologic 
syndromes also in patients exhibiting these BS.
Further insights into the origins of BSs may be derived from 
considering their developmental pattern and relationship to 
brain development. Psychoses, in particular of the schizophrenia-
spectrum, are considered a fundamentally neurodevelopmental 
disorder involving two critical time windows [early (perinatal) 
brain development and adolescence] that together produce the 
symptomatic manifestations of the disorder. In this framework, 
early developmental insults may lead to dysfunction of specific 
neural networks that would account for early and (in some cases) 
trait-like signs and symptoms, which may have little or no clinical 
significance. The development of a CHR state (e.g., by additional 
occurrence or an increase in frequency of COGDIS symptoms) 
might index an ongoing imbalance of excessive synaptogenesis/
pruning in critical networks, and ultimately the emergence of 
diagnostically relevant psychotic symptoms. This is supported by 
a recent analysis of two general population samples spanning the 
age of 8–40  years (66). Age seemed to affect the 14 perceptive 
and cognitive BSs included in COPER and COGDIS differently, 
indicating an age threshold of perceptive BS in late adolescents, 
around age 18, and of cognitive BSs in young adulthood, in the 
early twenties – with higher prevalence but reduced association to 
functional deficits and presence of mental disorder in the below-
threshold groups. Thereby, differential age effects seem to follow 
normal back-to-front brain maturation processes, during which 
BSs might occur as temporary, in most cases infrequently occur-
ring non-pathological disturbances. Their persistence or onset 
after conclusion of main brain maturation processes, however, 
might signify aberrant brain processes. Furthermore, an alterna-
tive or complementary explanation of this age-related pattern 
might be given against the background of decreasing brain plas-
ticity after myelination and pruning processes reach maturity in 
the early 20s (67): BSs developing in childhood and adolescence, 
or rather their underlying neurobiological aberrations, might be 
much better compensated for by the still developing brain and 
thus, despite the larger number of affected youths, might only be 
reported by them as infrequent, momentary phenomena. These 
assumptions might be examined in future studies (i) by cross-
sectionally comparing brain development in adolescents report-
ing BSs with and without clinical significance, (ii) by comparing 
subjects with an onset of BSs before and after age 18, and (iii) 
by comparing non-converters and converters to psychosis with 
regard to their onset and course of BSs.
In addition, if BSs reflect brain processes related to psychosis, 
then manifestation of BSs should closely be linked to genetic risk. 
Indeed, studies on first-degree relatives (7, 68–70) and schizo-
typal samples (71–73) indicated increased rates of BSs compared 
to HCs and non-schizophrenia-spectrum patients, respectively. 
In first-degree relatives, this involved more specific cognitive, 
perceptive and stress-tolerance-related BSs in particular (68). 
A recent genome-wide association study (74) identified 108 
genetic variants associated with biological pathways central to the 
pathophysiology of schizophrenia. Thus, another route of future 
studies could be to explore links between certain BSs and possibly 
related risk-variants, e.g., between certain cognitive BSs and SNPs 
involved in cognition related neurotransmission.
Additional insights into the neurobiological basis of BSs 
might also be gained by using pharmacological perturbations in 
healthy samples. Preliminary evidence indicates that ketamine 
as well as THC may be associated with the expression of BSs 
(22, 23). Further studies in healthy populations using a range 
of pharmacological models which target specific cannabinoid, 
glutamatergic, dopaminergic, and GABAergic systems could 
provide important information on the contribution of dysfunc-
tions in neurotransmitter systems and manifestation of BSs.
Finally, studying CHR patients at different stages may reveal 
the neurobiological correlates of BSs and evolution of schizo-
phrenia. Theoretical and empirical evidence suggests that BSs 
may constitute the earliest signposts, preceding the development 
of UHR and psychotic symptoms. Recent studies point toward 
anatomical and electrophysiological differences between BSs 
and UHR samples; but these findings require replication and 
extension with functional imaging approaches. Longitudinal 
investigations of individuals identified on the basis of BSs alone 
could provide crucial information on their neurobiological cor-
relates and potential progressive pathophysiological processes 
that might lead eventually to psychosis.
cONcLUsiON
In conclusion, despite the fact that BSs were in their original (and 
pioneering) formulation considered to be a direct manifestation 
of brain abnormalities in patients with schizophrenia, the nature 
of such abnormalities appear subtle and heterogeneous, requiring 
sophisticated methods of analyses to be detected. Our review sug-
gests that the CHR paradigm may constitute a fruitful paradigm 
to investigate the relationship between phenomenologically 
grounded perceptual and cognitive alterations and underlying 
abnormalities in the functionality of anatomical and functional 
brain networks. These insights may not only be useful for an 
improved general understanding of BSs but may ultimately give 
critical insights into the development of psychosis, which could 
be crucial for early diagnosis and intervention. Furthermore, 
as BSs are not only present in the initial prodromal phase, but 
throughout the course of the illness, they may also enable new 
insights into the neurobiological determinants of unfavorable 
outcomes including functional deterioration.
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